• Subscribe
    e

    Xconomy’s Digital Events →

    ▾
  • Xconomy National

  • Our
    Regions
    • National ›
      • Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
        Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
      View More in National ›
    • Europe ›
      • FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
        FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
      View More in Europe ›
    • Boston ›
      • Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
        Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
      View More in Boston ›
    • Boulder/Denver ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Indiana ›
    • New York ›
      • “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
        “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
      View More in New York ›
    • Philadelphia ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Philadelphia ›
    • Raleigh-Durham ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Raleigh-Durham ›
    • San Diego ›
      • Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
        Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
      View More in San Diego ›
    • San Francisco ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in San Francisco ›
    • Seattle ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Seattle ›
    • Texas ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Texas ›
    • Wisconsin ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Wisconsin ›
  • Topic
    Channels
    • Life Sciences›
        View More in Life Sciences ›
      • Healthtech›
          View More in Healthtech ›
        • Robotics and A.I.›
            View More in Robotics and A.I. ›
          • Startups›
              View More in Startups ›
          • Our
            Events
            • All Xconomy Events ›
          • Xconomy
            Insight
          Entry Author Date Location
          Dewpoint Therapeutics Taps Ex-Sanofi Executive Ameet Nathwani as CEO Frank Vinluan 10/13/20 Boston
          Invetx Appoints Bill Brondyk, Colin Giles to Executive Team Frank Vinluan 09/30/20 Boston
          Thrive Earlier Detection Taps CVS’s Asgarian as Chief Medical Officer Frank Vinluan 09/30/20 Boston
          Ex-Radius Health Exec Carmona Joins Rubius as Chief Financial Officer Frank Vinluan 09/28/20 Boston
          Freeline Therapeutics Promotes Corbau to Chief Scientific Officer Frank Vinluan 09/28/20 Europe
          Silence Therapeutics Taps Orchard’s Mark Rothera as President & CEO Frank Vinluan 09/14/20 Europe
          Synlogic Names Metera’s David Hava as Chief Scientific Officer Frank Vinluan 09/14/20 Boston
          Agios Exec Andrew Hirsch Jumps to C4 Therapeutics for CEO Role Frank Vinluan 09/08/20 Boston
          AlloVir Taps Merck’s Atillasoy as Chief Regulatory & Safety Officer Frank Vinluan 09/08/20 Boston
          Kura Oncology Adds Kyowa Kirin’s Stephen Dale as Chief Medical Officer Sarah de Crescenzo 08/25/20 San Diego
          Page 1 of 102 next page »

          Underwriters and Partners

          Xconomy Insight
          • Sept. 15 – Challenges of Implementing Innovation in Drug Discovery & Development

            Sponsored · Webinar

            Sept. 15 – Challenges of Implementing Innovation in Drug Discovery & Development

            Phenotypic Screening & Profiling to Understand a Compound's Disease Impact

            Eurofins Discovery
          • What to Include in Your Life Sciences Company Fundraising Pitch Deck

            Sponsored · Whitepaper

            What to Include in Your Life Sciences Company Fundraising Pitch Deck

            What the most successful life sciences fundraising pitch decks all have in common

            Brex
          • What’s Next in Neuroscience Therapies

            Sponsored · Whitepaper

            What’s Next in Neuroscience Therapies

            New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

          Xconomy on Demand

          We offer a number of ways to subscribe for free!

          Subscribe Now
          Informa Connect Logo Informa Connect Logo
          • Home
          • Privacy Policy
          • Security Disclosures
          • About
          • Contact Us
          • Archives
          • Advertise
          • Subscribe for Free

          © 2007-2022, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.